Literature DB >> 3492448

HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5.

M Melbye, L Kestens, R J Biggar, G M Schreuder, P L Gigase.   

Abstract

In the search for a genetic factor involved in the etiology of Kaposi's sarcoma, several studies have recently focused on a significantly increased HLA determinant, DR5, as well as a decreased DR3, among patients with both the classical and the AIDS-related form of Kaposi's sarcoma. To test the consistency of this phenomenon, we analysed the frequencies of HLA immunogenetic markers in 23 histologically confirmed Kaposi's sarcoma patients from Central Africa, where this tumor is endemic, and a local sex- and tribe-matched control group. No definite association was observed for any of the HLA antigens, including DR5 and DR3. We were not able to support the hypothesis that the same HLA-associated immune susceptibility factors are involved in all types of Kaposi's sarcoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492448     DOI: 10.1002/ijc.2910390210

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Kaposi's sarcoma in retrospect.

Authors:  C J Sanders
Journal:  Genitourin Med       Date:  1997-12

2.  Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study.

Authors:  James J Goedert; Maureen P Martin; Francesco Vitale; Carmela Lauria; Denise Whitby; Ying Qi; Xiaojiang Gao; Mary Carrington
Journal:  J Infect Dis       Date:  2015-08-12       Impact factor: 5.226

3.  Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis.

Authors:  Salum J Lidenge; Andrew V Kossenkov; For Yue Tso; Jayamanna Wickramasinghe; Sara R Privatt; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Paul M Lieberman; John T West; Charles Wood
Journal:  PLoS Pathog       Date:  2020-07-24       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.